Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells
出版年份 2020 全文链接
标题
Significance of aldo-keto reductase 1C3 and ATP-binding cassette transporter B1 in gain of irinotecan resistance in colon cancer cells
作者
关键词
Aldo-keto reductase 1C3, Irinotecan, Chemoresistance, Colon cancer, ATP-Binding cassette B1, Pregnane-X receptor
出版物
CHEMICO-BIOLOGICAL INTERACTIONS
Volume 332, Issue -, Pages 109295
出版商
Elsevier BV
发表日期
2020-10-20
DOI
10.1016/j.cbi.2020.109295
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Reversal of Apalutamide and Darolutamide Aldo-Keto Reductase 1C3-Mediated Resistance by a Small Molecule Inhibitor
- (2020) Ahmed Morsy et al. ACS Chemical Biology
- Irinotecan Induces Autophagy-Dependent Apoptosis and Positively Regulates ROS-Related JNK- and P38-MAPK Pathways in Gastric Cancer Cells
- (2020) Qingyun Zhu et al. OncoTargets and Therapy
- Pathophysiological roles of autophagy and aldo-keto reductases in development of doxorubicin resistance in gastrointestinal cancer cells
- (2019) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity
- (2018) Irina Druzhkova et al. Clinical Colorectal Cancer
- Pathophysiology of mitochondrial lipid oxidation: Role of 4-hydroxynonenal (4-HNE) and other bioactive lipids in mitochondria
- (2017) Mengqing Xiao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Implications of ABCG2 Expression on Irinotecan Treatment of Colorectal Cancer Patients: A Review
- (2017) Dorte Lisbet Nielsen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Controversy about pharmacological modulation of Nrf2 for cancer therapy
- (2017) Lidija Milkovic et al. Redox Biology
- 4-Hydroxy-2-nonenal: a critical target in oxidative stress?
- (2016) Mason Breitzig et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Roles of aldo-keto reductases 1B10 and 1C3 and ATP-binding cassette transporter in docetaxel tolerance
- (2016) Toshiyuki Matsunaga et al. FREE RADICAL RESEARCH
- Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell Lines
- (2016) Kshitij Verma et al. ACS Medicinal Chemistry Letters
- Induction of aldo-keto reductases (AKR1C1 and AKR1C3) abolishes the efficacy of daunorubicin chemotherapy for leukemic U937 cells
- (2014) Toshiyuki Matsunaga et al. ANTI-CANCER DRUGS
- Pathophysiological roles of aldo–keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers
- (2012) Toshiyuki Matsunaga et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Somatic mutations of the KEAP1 gene in common solid cancers
- (2012) Nam Jin Yoo et al. HISTOPATHOLOGY
- Mitogen-activated protein kinase (MEK/ERK) inhibition sensitizes cancer cells to centromere-associated protein E inhibition
- (2012) Patrick A. Mayes et al. INTERNATIONAL JOURNAL OF CANCER
- Decreased expression of 17β-hydroxysteroid dehydrogenase type 1 is associated with DNA hypermethylation in colorectal cancer located in the proximal colon
- (2011) Agnieszka Anna Rawłuszko et al. BMC CANCER
- Pregnane X receptor activation induces FGF19-dependent tumor aggressiveness in humans and mice
- (2011) Hongwei Wang et al. JOURNAL OF CLINICAL INVESTIGATION
- Overcoming drug resistance by regulating nuclear receptors
- (2010) Taosheng Chen ADVANCED DRUG DELIVERY REVIEWS
- Targeting the p38 MAPK Pathway Inhibits Irinotecan Resistance in Colon Adenocarcinoma
- (2010) S. Paillas et al. CANCER RESEARCH
- Roles of rat and human aldo–keto reductases in metabolism of farnesol and geranylgeraniol
- (2010) Satoshi Endo et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): Overview and structural insights
- (2010) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Pregnane X Receptor (PXR) expression in colorectal cancer cells restricts irinotecan chemosensitivity through enhanced SN-38 glucuronidation
- (2010) Caroline Raynal et al. Molecular Cancer
- Steroid Sulfatase and Estrogen Sulfotransferase in Colon Carcinoma: Regulators of Intratumoral Estrogen Concentrations and Potent Prognostic Factors
- (2009) R. Sato et al. CANCER RESEARCH
- Characterization of the cancer chemopreventive NRF2-dependent gene battery in human keratinocytes: demonstration that the KEAP1–NRF2 pathway, and not the BACH1–NRF2 pathway, controls cytoprotection against electrophiles as well as redox-cycling compounds
- (2009) A.Kenneth MacLeod et al. CARCINOGENESIS
- Nrf2: friend or foe for chemoprevention?
- (2009) T. W. Kensler et al. CARCINOGENESIS
- Structure-Guided Design, Synthesis, and Evaluation of Salicylic Acid-Based Inhibitors Targeting a Selectivity Pocket in the Active Site of Human 20α-Hydroxysteroid Dehydrogenase (AKR1C1)
- (2009) Ossama El-Kabbani et al. JOURNAL OF MEDICINAL CHEMISTRY
- Aldo-keto reductase 1C3 expression in MCF-7 cells reveals roles in steroid hormone and prostaglandin metabolism that may explain its over-expression in breast cancer
- (2009) Michael C. Byrns et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Induction of 1C aldoketoreductases and other drug dose-dependent genes upon acquisition of anthracycline resistance
- (2009) Zachary W. Veitch et al. Pharmacogenetics and Genomics
- Drugs Behave as Substrates, Inhibitors and Inducers of Human Cytochrome P450 3A4
- (2008) Shu-Feng Zhou CURRENT DRUG METABOLISM
- The Aldo-Keto Reductase Superfamily and its Role in Drug Metabolism and Detoxification
- (2008) Oleg A. Barski et al. DRUG METABOLISM REVIEWS
- Aberrant pre-receptor regulation of estrogen and progesterone action in endometrial cancer
- (2008) Tina Šmuc et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started